Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tiratricol-Containing Products Not Dietary Supplements - U.S. Judge

This article was originally published in The Tan Sheet

Executive Summary

Tiratricol cannot be marketed as a dietary supplement because it has been the subject of an investigational new drug application since 1990, a Cape Girardeau, Mo. federal judge has ruled in an FDA enforcement action against Syntrax Innovations.
Advertisement

Related Content

Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
Tiratricol
Tiratricol
Tiratricol
Triax Supplement Distribution Barred By Court Order
Triax Weight Loss Supplement Distribution Halted At FDA's Request
Triax Weight Loss Supplement Distribution Halted At FDA's Request

Topics

Advertisement
UsernamePublicRestriction

Register

PS092293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel